Journal of Cellular & Molecular Anesthesia
Outlines
Predictive Molecular Blood Biomarkers in Non-Small Cell Lung Cancer
Abdolreza Mohamadnia
1,*, Mohammad Hoseine Talischi2, Minoo Mahmoodi2, Naghmeh Bahrami3, Abdollah Farhadinasab4Abstract
Background: Lung cancer is characterized by the uncontrolled growth of cells in the lung tissue. The purpose of the present study was to investigate the expression of MUC1 mRNA and CK19 mRNA biomarkers in patients with non-small-cell lung carcinoma (NSCLC).
Materials and Methods: In this case-control research, thirty samples of cancer blood, thirty samples of cancer tissue, and the same number of healthy samples were prepared. Samples were collected and RNA was extracted, then cDNA was made and gene expression was measured using Real-Time PCR.
Results: Among non-small-cell lung carcinoma patients, the MUC1 mRNA marker was positive for 19 individuals while in the healthy group, it was reported positive in 5 out of 30 individuals. In the patients' group, the CK19 mRNA marker was positive for 16 individuals while in the healthy group, in 6 out of 30 individuals.
Conclusion: The MUC1 mRNA and CK19 mRNA as lung cancer tumor markers were reliable and sensitive; however, further studies are recommended
References
- 1.References are in the PDF file of the article.
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Ectopic Expression of miRNA-21 and miRNA-205 in Non-Small Cell Lung Cancer
Azimi SA, Sadegh Nia HR, Mosavi Jarrahi A, Jamaati HR, Kazempour Dizaji M, et al. Ectopic Expression of miRNA-21 and miRNA-205 in Non-Small Cell Lung Cancer. Int J Cancer Manag. 2019;12(1):e85456. doi: https://doi.org/10.5812/ijcm.85456
Analysis of Blood and Tissue miR-191, miR-22, and EGFR mRNA as Novel Biomarkers for Breast Cancer Diagnosis
Shahi A, Bahrami N, Rafiei Tabatabaei R, Kazempour Dizaji M, Jamaati H, et al. Analysis of Blood and Tissue miR-191, miR-22, and EGFR mRNA as Novel Biomarkers for Breast Cancer Diagnosis. Int J Cancer Manag. 2022;15(1):e117612. doi: https://doi.org/10.5812/ijcm.117612
LncRNA GHET1 and LncRNA ZXF2 as New Biomarkers in Oral Squamous Cell Carcinoma in Relation to Clinicopathological Variables
Konani M, Pourhoseini M, Hashemi M, Entezari M, Khaleghi S. LncRNA GHET1 and LncRNA ZXF2 as New Biomarkers in Oral Squamous Cell Carcinoma in Relation to Clinicopathological Variables. Int J Cancer Manag. 2023;16(1):e121372. doi: https://doi.org/10.5812/ijcm-121372
Expression of Five Important Biomarkers in Non-small Cell Lung Cancer: MicroRNAs-128, miR-335-5p, miR-1254, VEGF, and K-RAS
Yari E, Mohamadnia A, Bahrami N, Salahshourifar I. Expression of Five Important Biomarkers in Non-small Cell Lung Cancer: MicroRNAs-128, miR-335-5p, miR-1254, VEGF, and K-RAS. Int J Cancer Manag. 2024;17(1):e151012. doi: https://doi.org/10.5812/ijcm-151012
Evaluation of Potential miR-302, miR-132, miR-205, and miR-126 as Biomarkers for Laryngeal Squamous Cell Carcinoma
Oliyaierezaie A, Zarredar H, Asadi M, Zafari V, Shanebandi D, et al. Evaluation of Potential miR-302, miR-132, miR-205, and miR-126 as Biomarkers for Laryngeal Squamous Cell Carcinoma. Int J Cancer Manag. 2023;16(1):e136321. doi: https://doi.org/10.5812/ijcm-136321
Crossmark
Checking
- Scopus by DOI: 3
Last Update: 1 month ago
- Scopus by Title: 3
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 1
Last Update: 1 day ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):